iShares US Pharmaceuticals ETF
IHE
IHE
102 hedge funds and large institutions have $321M invested in iShares US Pharmaceuticals ETF in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 43 increasing their positions, 32 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $404M → $321M (-$83M)
74% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 23
Holders
102
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$4.99M | |
| 2 | +$4.25M | |
| 3 | +$3.58M | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$3.55M |
| 5 |
Jane Street
New York
|
+$3.43M |
Top Sellers
| 1 | -$17M | |
| 2 | -$7.23M | |
| 3 | -$4.22M | |
| 4 |
UFF
USA Financial Formulas
Ada,
Michigan
|
-$3.99M |
| 5 |
LPL Financial
San Diego,
California
|
-$3.02M |